Breadcrumb Home NeuroGap People NeuroGAP-Psychosis 1.0 (2016-2023) Principal Investigators Karestan Koenen Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Dickens Akena Makerere University, Uganda Lukoye Atwoli Moi University, Kenya Symon Kariuki KEMRI-Wellcome, Kenya Charles Newton KEMRI-Wellcome, Kenya KEMRI-Wellcome, Kenya, KEMRI-Wellcome, Kenya, Dan Stein University of Cape Town, South Africa Solomon Teferra Addis Ababa University, Ethiopia Zuki Zingela Walter Sisulu University, South Africa Ó³»´«Ã½/Harvard program staff Anne Stevenson Program Director Rocky Stroud II Assistant Program Director Mark Baker Database Manager NeuroDev Principal Investigators Elise Robinson Ó³»´«Ã½ Amina Abubakar KEMRI-Wellcome, Kenya University of Cape Town, South Africa Charles Newton KEMRI-Wellcome, Kenya KEMRI-Wellcome, Kenya, KEMRI-Wellcome, Kenya, Research Director Dr. Celia van der Merwe Ó³»´«Ã½ GINGER Lori Chibnik Principal Investigator Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Bizu Gelaye Associate Director Ó³»´«Ã½ Harvard T.H. Chan School of Public Health Kristianna Post Program Director Ó³»´«Ã½ Harvard T.H. Chan School of Public Health NeuroGenE (2017-2023) Principal Investigator University of Oxford, UK NeuroGap About GINGER Meet the Research Fellows 2020-2024 Cohort 2017-2019 Cohort NeuroDev NeuroGAP-Psychosis NeuroGenE People Latest news News 05.01.2026 Single-molecule tracker illuminates workings of cancer-related proteins News 04.22.2026 Clinical trial of a prion disease drug candidate begins enrolling participants News 04.15.2026 Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution News 04.14.2026 Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics All news
News 04.15.2026 Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution
News 04.14.2026 Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics